› Forums › General Melanoma Community › What to do?
- This topic has 9 replies, 3 voices, and was last updated 13 years, 10 months ago by
James from Sydney.
- Post
-
- March 31, 2012 at 3:10 am
Thanks for everyone's input so far regarding my dad's treatment. I feel quite powerless at the moment. There are very few trials here in Australia at the moment. The only option is continue on BRAF while some tumors are stable others slight increase and add the MEK to it. We meet his oncologist on the 11 of April to discuss a plan.
Thanks for everyone's input so far regarding my dad's treatment. I feel quite powerless at the moment. There are very few trials here in Australia at the moment. The only option is continue on BRAF while some tumors are stable others slight increase and add the MEK to it. We meet his oncologist on the 11 of April to discuss a plan.
Can I ask why we would remove the three/4 subs in and perhaps SRS surgery on liver tumors which are stable. The one in the spleen could perhaps be removed too or spleen removed? I know that must sound really crazy and I know it won't eliminate the disease but surely it will give my dad more time. What are you're thoughts.
There may be an E7080 trial in Sydney and we are Melbourne and BEZ235 plus MEK162 inhibitor trial in Melbourne.
How poor is that selection?
Sorry feel flat
Nahmi
- Replies
-
-
- March 31, 2012 at 4:40 am
Nahmi, I think that continuing on the BRAF inhibitor and adding MEK to it is a reasonable option at the moment. I also feel it would be an idea to consult a surgical oncologist regarding the liver mets. It is possible that surgery might be viable.
The fact that some tumours are stable is encouraging. However, as there are very limited number of clinical trials available here I think that Yervoy should not be ruled out.
Take care
Frank from Australia
-
- March 31, 2012 at 4:40 am
Nahmi, I think that continuing on the BRAF inhibitor and adding MEK to it is a reasonable option at the moment. I also feel it would be an idea to consult a surgical oncologist regarding the liver mets. It is possible that surgery might be viable.
The fact that some tumours are stable is encouraging. However, as there are very limited number of clinical trials available here I think that Yervoy should not be ruled out.
Take care
Frank from Australia
-
- March 31, 2012 at 4:40 am
Nahmi, I think that continuing on the BRAF inhibitor and adding MEK to it is a reasonable option at the moment. I also feel it would be an idea to consult a surgical oncologist regarding the liver mets. It is possible that surgery might be viable.
The fact that some tumours are stable is encouraging. However, as there are very limited number of clinical trials available here I think that Yervoy should not be ruled out.
Take care
Frank from Australia
-
- April 3, 2012 at 7:27 am
Hi Nahmi, i think there maybe a PD-1 Trial accruing at Westmead and Newcastle, my email is jeconomi@bigpond.net.au i will have more details tomorrow so send me your email and i will forward you the contact.
best wishes
James
-
- April 3, 2012 at 7:27 am
Hi Nahmi, i think there maybe a PD-1 Trial accruing at Westmead and Newcastle, my email is jeconomi@bigpond.net.au i will have more details tomorrow so send me your email and i will forward you the contact.
best wishes
James
-
- April 3, 2012 at 7:27 am
Hi Nahmi, i think there maybe a PD-1 Trial accruing at Westmead and Newcastle, my email is jeconomi@bigpond.net.au i will have more details tomorrow so send me your email and i will forward you the contact.
best wishes
James
-
- You must be logged in to reply to this topic.